Enanta Pharmaceuticals
ENTA
#7695
Rank
S$0.56 B
Marketcap
S$19.51
Share price
2.30%
Change (1 day)
94.11%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -S$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$65.32 Million. In 2024 the company made an earning of -S$0.13 Billion, an increase over its 2023 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.11 Billion-20.03%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$86.28 Million-407.13%
2019 S$28.08 M-78.63%
2018 S$0.13 B117.97%
2017 S$60.31 M-574.65%
2016 -S$12.71 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.82 Million-137.98%
2012 S$60.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.54 B-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.38 B-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$8.51 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.53 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.98 B-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.39 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA